Pegylated interferon alfa 2b and ribavirin for hepatitis C patients who were nonresponders to previous

被引：9
|
作者：
Lawitz, EJ
Bala, NS
Becker, S
Brown, G
Davis, M
Dhar, R
Ganeshappa, KP
Gordon, S
Holtzmuller, K
Jeffries, M
Li, JJ
Monsour, H
Nader, P
Rosenfield, T
Tolman, K
Kadakia, S
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)83957-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A783 / A784
页数：2
相关论文
共 50 条
  • [31] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    PN Rao
    Abraham Koshy
    Jacob Philip
    Narayanan Premaletha
    Joy Varghese
    Krishnasamy Narayanasamy
    Samir Mohindra
    Nitin Vikas Pai
    Manoj Kumar Agarwal
    Ashokna Konar
    Hasmukh B Vora
    World Journal of Hepatology, 2014, (07) : 520 - 526
  • [32] Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C
    Poynard, T
    McHutchison, J
    Manns, M
    Trepo, C
    Lindsay, K
    Goodman, Z
    Ling, MH
    Albrecht, J
    GASTROENTEROLOGY, 2002, 122 (05) : 1303 - 1313
  • [33] Pegylated interferon alfa-2b plus ribavirin for treatment of chronic hepatitis C
    Rao, P. N.
    Koshy, Abraham
    Philip, Jacob
    Premaletha, Narayanan
    Varghese, Joy
    Narayanasamy, Krishnasamy
    Mohindra, Samir
    Pai, Nitin Vikas
    Agarwal, Manoj Kumar
    Konar, Ashoknanda
    Vora, Hasmukh B.
    WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (07) : 520 - 526
  • [34] Pegylated interferon alfa and ribavirin for children with chronic hepatitis C
    Irit Rosen
    Michal Kori
    Orly Eshach Adiv
    Baruch Yerushalmi
    Nataly Zion
    Ron Shaoul
    World Journal of Gastroenterology, 2013, (07) : 1098 - 1103
  • [35] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy and in combination therapy relapsers
    Jacobson, IM
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Rovner, D
    Brass, C
    GASTROENTEROLOGY, 2002, 122 (04) : A626 - A626
  • [36] Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy, and in combination therapy relapsers
    Jacobson, IM
    Russo, MW
    Brown, RS
    Lebovics, E
    Min, A
    Esposito, S
    Tobias, H
    Klion, F
    Pizov, O
    Brass, C
    GASTROENTEROLOGY, 2001, 120 (05) : A383 - A383
  • [37] Reversible decompensated liver disease as a possible complication of pegylated-interferon alfa 2B and ribavirin for recurrent hepatitis C
    Mukherjee, S
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (06) : 723 - 724
  • [38] De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infection
    Jose L. Tovar
    Maria Buti
    Alfonso Segarra
    Joaquim Majó
    Rafael Esteban
    International Urology and Nephrology, 2008, 40 : 539 - 541
  • [39] The effect of induction pegylated interferon alfa 2b and ribavirin on early virologic response in genotype 1 chronic hepatitis C
    Lawitz, EJ
    Harrison, SA
    Cantu, NS
    Davis, M
    Perkel, M
    Vemuru, R
    Nguyen, T
    Kadakia, S
    Ganeshappa, KP
    Diamond, K
    Matossian, H
    Box, TD
    Ghandour, E
    GASTROENTEROLOGY, 2004, 126 (04) : A723 - A723
  • [40] De novo nephrotic syndrome following pegylated interferon alfa 2b/ribavirin therapy for chronic hepatitis C infection
    Tovar, Jose L.
    Buti, Maria
    Segarra, Alfonso
    Majo, Joaquim
    Esteban, Rafael
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2008, 40 (02) : 539 - 541
12345